Life Molecular Imaging

• NCT05337774

  Phase 1, Terminated, 18 people, 20 Apr 2022

• NCT05187546

  Phase 1, Completed, 15 people, 12 Jan 2022

• NCT04715750

  Phase 1, Completed, 10 people, 20 Jan 2021

• Air pollution is associated with sex-specific longitudinal changes in astrocytic and neuroinflammatory processes linked to cognitive decline in Alzheimer's disease at-risk individuals

  Consulting or advice, Fees or honoraria, Grants or research support, 1 Oct 2026

• A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease

  Fees or honoraria, 21 Sept 2026

• A scalable workflow using digital cognitive assessment and pTau217 for MCI detection

  Fees or honoraria, Grants or research support, 17 Sept 2026

• Associations of physical fitness with brain structure, pathology and cognition in cognitively normal older adults

  Grants or research support, 16 Sept 2026

• Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study

  Consulting or advice, Fees or honoraria, Board or leadership role, 3 Sept 2026

• Changes in serum β-synuclein precede blood biomarkers of Alzheimer pathology in Down syndrome

  Consulting or advice, Fees or honoraria, Board or leadership role, 1 Sept 2026

• Evaluating inclusion of continuous multivariable cognitive scores for operational enrichment of preclinical Alzheimer's disease trials: a retrospective emulation study

  Grants or research support, 8 Aug 2026

• Low-dose CT for MRI-free quantification of tau PET in Alzheimer's disease: a multicentre, cross-sectional, comparison study

  Consulting or advice, Fees or honoraria, Board or leadership role, 3 Aug 2026

• CSF fibrinogen predicts longitudinal Tau accumulation in cognitively unimpaired older adults

  Consulting or advice, Fees or honoraria, Board or leadership role, 1 Aug 2026

• Divergent white matter metabolic signature patterns indicate impending cognitive decline in aging and dementia

  Consulting or advice, 19 Mar 2026

• Plasma Proteomic Analysis of APOE ε4 Homozygotes Identifies Preclinical Alzheimer's Disease Alterations Potentially Treatable with Semaglutide

  Consulting or advice, Fees or honoraria, Board or leadership role, 17 Feb 2026

• Cognitive training gain transfer in cognitively healthy aging: per protocol results of the German AgeGain study

  Grants or research support, 26 Aug 2025

Sources: pubmed.ncbi.nlm.nih.gov